Oluwadamilola Oluyede
Orthopaedic Surgery · Bakersfield, CANPI 1558758185
Payments from drug & device makers
Across 98 payments — averaging $247.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Xtant Medical Inc$7K
- Spineart USA Inc$6K
- Globus Medical$5K
- Surgalign Spine Technologies, Inc.$2K
- Centinel Spine, LLC$2K
- Medtronic$740
- plus $1K from 10 others
What the payments were for
- Consulting fees$3,00012%
- Speaking & faculty fees$6,70028%
- Travel & lodging$9,04737%
- Food & beverage$5,48423%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Xtant Medical Inc | 1 | $6,700 |
| Spineart USA Inc | 10 | $6,104 |
| Globus Medical(2 entities) | 33 | $4,952 |
| Surgalign Spine Technologies, Inc. | 13 | $2,365 |
| Centinel Spine, LLC | 9 | $1,904 |
| Medtronic | 9 | $740 |
| Alphatec Spine, Inc | 4 | $516 |
| Cerapedics Inc. | 2 | $217 |
| Boston Scientific | 8 | $210 |
| Orthofix Medical, Inc. | 2 | $124 |
| Axogen | 1 | $114 |
| Nevro Corp. | 2 | $87 |
| Johnson & Johnson | 1 | $83 |
| Stryker | 1 | $53 |
| Intrinsic Therapeutics | 1 | $40 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sable$2,255
- COFLEX INTERLAMINAR TECHNOLOGY, 10MM$1,917
- PRODISC L$1,661
- PERLA C$1,636
- ExcelsiusGPS Robotic Navigation System$1,109
- COFIX IMPLANT 10 MM$938
- FORTILINK-L IBF SYSTEM WITH TETRAFUSE 3D TECHNOLOGY$938
- FORTILINK CAGES WITH TIPLUS TECHNOLOGY$938
- ARAI SURGICAL NAVIGATION SYSTEM$938
- Scarlet AL-T$862
- INVICTUS OPEN$265
- UNID_PASS$236
- INTELLIS ADAPTIVESTIM$225
- Other - Miscellaneous$198
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$167
- XLIF$162
- CORBEL$158
- Perla TL$152
- KYPHON EXPRESS II KYPHOPAK TRAY$120
- AVANCE NERVE GRAFT$114
How this compares
$24,231 in reported general payments places this provider in the 80th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 20 | $2,590 |
| Gabapentin | 195 | $1,393 |
| Pregabalin | 71 | $1,079 |
| Cyclobenzaprine Hcl | 154 | $908 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 80 | $837 |
| Diclofenac Sodium | 15 | $369 |
| Tizanidine Hcl | 51 | $294 |
| Methylprednisolone | 46 | $245 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $238 |
| Oxycodone Hcl | 13 | $154 |
| Meloxicam | 71 | $138 |
| Tramadol Hcl | 24 | $97 |
| Baclofen | 11 | $87 |
| Ibuprofen | 15 | $72 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Bakersfield
- Bradford HackArcadia$18.3M
- Robert GorabOrange$14.5M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Peter NewtonSan Diego$7M
- Nirav AminPlacentia$5.8M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Sigurd BervenSan Francisco$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.